Skip to content

Comparison of the efficacy of enteral nutrition preparations with animal-based and plant-based protein in patients with high-grade pneumonia

Comparison of the efficacy of enteral nutrition preparations with animal-based and plant-based protein in patients with high-grade pneumonia

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077802
Enrollment
Unknown
Registered
2023-11-20
Start date
2023-12-01
Completion date
Unknown
Last updated
2023-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pneumonia

Interventions

Group A:Nutritional support with 20g of whey protein powder daily.
Group B:Nutritional support with 20g of soy protein powder daily.
Group C:Nutritional support with 10g of whey protein and 10g of soy protein powder daily.

Sponsors

Chengdu Eighth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
80 Years to 110 Years

Inclusion criteria

Inclusion criteria: 1. Age = 80 years old; 2. During my hospitalization in our hospital, I was diagnosed with pneumonia and pulmonary infection; 3. Conforming to the diagnosis of malnutrition; 4. Patients who are fed or consumed through a gastric or intestinal tube; 5. During the research process, no eggs or milk were infused; 6. The patient or family member fully understands the research protocol, voluntarily participates in this study, and signs a written informed consent form.

Exclusion criteria

Exclusion criteria: 1. Severe cardiovascular, hepatic, respiratory, urinary, neurological, psychiatric, systemic, or immunodeficiency disorders that, in the judgment of the investigator, make participation in the study inappropriate; 2. Hypersensitivity to the test product; 3. History of mechanical obstruction of the bowel or significant clinical manifestations; 4. Active gastrointestinal tract disorders, pancreatitis; 5. Received any other experimental medication or participated in another dry dry-agency clinical trial in the 3 months prior to the screening period; and 6. Unwillingness to sign the informed consent form or failure to follow the study procedures.

Design outcomes

Primary

MeasureTime frame
albumin;total protein;

Secondary

MeasureTime frame
Calf circumference;prealbumin;mini nutritional assessment-short form;hemoglobin;

Countries

China

Contacts

Public ContactMingyu Tian

Chengdu Eighth People's Hospital

792007981@qq.com+86 180 0053 1710

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026